301-315 of 334
Solving the Mystery of Restless Leg Syndrome
NeuroFrontiersSolving the Mystery of Restless Leg Syndrome
Anthony Alessi, MD
Carl Ansevin, MD
Updates on Familial Dysautonomia Research: How a Fatal Disease Became Manageable
Focus on Children's HealthUpdates on Familial Dysautonomia Research: How a Fatal Disease Became Manageable
Berish Rubin, PhD
Bruce Bloom, DDS, JD
The Clinically Broken Heart: Stress-Induced Cardiomyopathy
Heart MattersThe Clinically Broken Heart: Stress-Induced Cardiomyopathy
Janet Wright, MD
Scott Sharkey, MD
Bruce Bloom, DDS, JD
Charles Mullighan, MBBS, MSc, MD
Guillain-Barre Syndrome and the H1N1 Vaccine in Context
NeuroFrontiersGuillain-Barre Syndrome and the H1N1 Vaccine in Context
Anthony Alessi, MD
James Sejvar, MD
Michael Greenberg, MD
Anne Louise Oaklander, MD, PhD
- advertisement
Sensation and the Brain: Case Study of an Itch
Focus on Neurology and PsychiatrySensation and the Brain: Case Study of an Itch
Michael Greenberg, MD
Anne Louise Oaklander, MD, PhD
Bruce Bloom, DDS, JD
David J. Kuter, MD
Helping Patients and Families Understand Fragile X Syndrome
Clinician's RoundtableHelping Patients and Families Understand Fragile X Syndrome
Mark Nolan Hill, MD
Randi Hagerman, MD
Treating Fragile X Syndrome and Related Disorders
Clinician's RoundtableTreating Fragile X Syndrome and Related Disorders
Mark Nolan Hill, MD
Randi Hagerman, MD
Understanding Fragile X Syndrome and Related Conditions
Clinician's RoundtableUnderstanding Fragile X Syndrome and Related Conditions
Mark Nolan Hill, MD
Randi Hagerman, MD
Hypertrophic Cardiomyopathy: What to Know, and What to Do
Focus on Sports MedicineHypertrophic Cardiomyopathy: What to Know, and What to Do
Michael Greenberg, MD
- advertisement
Maurice Pickard, MD
William Gahl, MD, PhD
Stephen Groft, PharmD
Finding & Developing Drugs for Rare Conditions
Clinician's RoundtableFinding & Developing Drugs for Rare Conditions
Bruce Japsen
Jeffrey Aronin, MBA
Orphan Drug Act: 25 Years of Treating Rare Illnesses
Clinician's RoundtableOrphan Drug Act: 25 Years of Treating Rare Illnesses
Bruce Japsen
Jeffrey Aronin, MBA
